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Letters to the EditorFurther evidence for the relevance of TLR2 gene variants
in spontaneous bacterial peritonitisEditor:
ad with interest the recent study on the association
n Toll-like receptor (TLR) 2 gene polymorphisms and
neous bacterial peritonitis (SBP) by Hans Dieter Nischalke
lleagues published in the Journal of Hepatology [1]. As a
ane-bound pattern recognition receptor that is expressed
riety of immune cells, TLR2 can either act as a homodimer
heterodimers with TLR1 or TLR6 to recognize an
ed spectrum of microbial lipopeptides from Gram-positive
am-negative bacteria [2]. Nischalke et al. reported a higher
SBP in patients with increasing numbers of tandem GT
in intron 2 of the TLR2 gene, which correlated with the
ygous TLR2 promoter variant 16934A>T (rs4696480).
y, they also observed a trend toward increased risk of
presence of the TLR2 Arg753Gln variant (rs5743708) that
t reach statistical signiﬁcance (p = 0.089). Despite its low
frequency in Caucasian subjects (3%) [1], the TLR2
Gln polymorphism has recently been found to be involved
riety of infectious diseases, including endocarditis [3], uri-
act infections and recurrent bacterial infections in children
reexisting infections in critically ill patients admitted to
ensive care unit [6], and infection recurrence in patients
ram-positive bacterial infections after liver transplantation
urther substantiate the role of TLR2 polymorphisms in SBP,
ermined the prevalence of the gene variants Arg753Gln,
His (rs5743704), and 16934A>T in an independent
of 120 patients with cirrhosis and ascites from the Jena
sity Hospital (Germany) that were recruited for a recent
r study [8]. The majority of subjects were male (68%)
ffered from alcoholic cirrhosis (76%); median age and
score were 59 years (range: 26–87) and 16.5 (6–35),
ively. SBP, deﬁned by an ascitic ﬂuid neutrophil count
ll, was diagnosed in 20 (17%) subjects during one hospital
ve additional subjects (4%) had no SBP during the study
but a documented prior episode of SBP at study entry.
traction from EDTA whole blood and allelic discrimination
TLR2 gene variants using PCR with probe-based ﬂuores-
elting curve analysis were successful in 119 out of 120
d subjects. Distributions of genotypes did not deviate
ardy–Weinberg equilibrium for each of the three single
tide polymorphisms (SNPs). The genotype frequencies
8.6% AA, 48.7% AT, and 22.7% TT for SNP 16934A>T;
GG, 7.6% GA, and 0% AA for SNP Arg753Gln; and 89.1%
1% CA, and 0.8% AA for SNP Pro631His, respectively; thus,
rable to the frequencies reported by Nischalke et al. [1].
ur cohort, we did not observe a statistically signiﬁcant
tion of SBP with the TLR2 polymorphisms 16934A>T
90 in two-sided Fisher’s exact test) or Pro631His
00) (Fig. 1A and C). Notably, patients carrying the TLR2
rphism Arg753Gln (GA genotype) more often had SBP
(5/9 [55.6%]) than patients with the GG genotype (20/110
[18.2%]; p = 0.019) (Fig. 1B). All observed cases of SBP in carriers
of the Arg753Gln variant were culture-negative. Ascitic ﬂuid pro-
tein concentrations tended to be higher in patients with the TLR2
Arg753Gln polymorphism (20.6 vs. 12.4 g/L; p = 0.063). Impor-
tantly, subjects with the TLR2 Arg753Gln variant did not differ
from subjects with GG genotype with respect to the other risk
factors for SBP, such as MELD score, age, bilirubin, serum albu-
min, prior variceal hemorrhage, or proton pump inhibitor use
(all p >0.5). One of the nine subjects with the Arg753Gln variant
was also carrier of a NOD2 risk variant (rs2066847) predisposing
to SBP [8,9]. Median survival of subjects with the Arg753Gln var-
iant was 211 days compared to 339 days in subjects with the GG
genotype (p = 0.668 in log rank test). Likewise, the 16934A>T
polymorphism (p = 0.364) and the Pro631His polymorphism
(p = 0.351) were not associated with a shorter survival.
Differences in the study design (no follow-up period after hos-
pital discharge), the incidence of Gram-positive SBP (2 vs. 7 cases)
and variances in the association of the number of tandem GT
repeats with the 16934T>A polymorphism may have contrib-
uted to the fact that we did not observe an association of SBP
with the 16934 TT genotype in our cohort. Moreover, the tan-
dem GT repeat polymorphism is also in strong linkage disequilib-
rium with the Arg753Gln polymorphism in Caucasians [10] and
may therefore be differentially associated with the TLR2 SNPs
16934T>A and Arg753Gln in different cohorts.
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Fig. 1. Frequency of patients with SBP (current or prior) and without any
episode of SBP stratiﬁed with respect to the indicated genotypes of the TLR2
polymorphisms (A) 16934A>T, (B) Arg753Gln, and (C) Pro631His. Two-sided
Fisher’s exact tests for subjects with and without SBP were calculated for all
statistical comparisons; p values are indicated.
Journal of Hepatology 2012 vol. 56 j 1207–1217
In summary, our data indicate an increased risk of SBP in cir-
rhotic patients carrying the TLR2 Arg753Gln polymorphism (OR
5.6; 95% CI 1.4–22.8) and add further evidence for the relevance
of TLR2 signaling in the development of SBP provided by Nis-
chalke et al. A prospective validation of potential genetic markers
in larger cohorts is needed to conclusively evaluate the geneti-
cally attributable risk for SBP in patients with cirrhosis and
ascites.
Conﬂict of interest
The authors who have taken part in this study declared that they
do not have anything to disclose regarding conﬂict of interest
with respect to this manuscript.
References
[1] Nischalke HD, Berger C, Aldenhoff K, Thyssen L, Gentemann M, Grünhage F,
et al. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are
associated with increased risk for spontaneous bacterial peritonitis in liver
cirrhosis. J Hepatol 2011;55:1010–1016.
[2] Farhat K, Riekenberg S, Heine H, Debarry J, Lang R, Mages J, et al.
Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum
but does not lead to differential signaling. J Leukoc Biol 2008;83:692–701.
[3] Bustamante J, Tamayo E, Flórez S, Telleria JJ, Bustamante E, López J, et al.
Toll-like receptor 2 R753Q polymorphisms are associated with an increased
risk of infective endocarditis. Rev Esp Cardiol 2011;64:1056–1059.
[4] Tabel Y, Berdeli A, Mir S. Association of TLR2 gene Arg753Gln polymorphism
with urinary tract infection in children. Int J Immunogenet
2007;34:399–405.
[5] Kutukculer N, Yeniay BS, Aksu G, Berdeli A. Arg753Gln polymorphism of the
human toll-like receptor-2 gene in children with recurrent febrile infections.
Biochem Genet 2007;45:507–514.
[6] Ahmad-Nejad P, Denz C, Zimmer W, Wacker J, Bugert P, Weiss C, et al. The
presence of functionally relevant toll-like receptor polymorphisms does not
signiﬁcantly correlate with development or outcome of sepsis. Genet Test
Mol Biomarkers 2011;15:645–651.
[7] Lee S-O, Brown RA, Kang SH, Abdel-Massih RC, Razonable RR. Toll-like
receptor 2 polymorphism and Gram-positive bacterial infections after liver
transplantation. Liver Transpl 2011;17:1081–1088.
[8] Bruns T, Peter J, Reuken PA, Grabe DH, Schuldes SR, Brenmoehl J, et al. NOD2
gene variants are a risk factor for culture-positive spontaneous bacterial
peritonitis and monomicrobial bacterascites in cirrhosis. Liver Int
2012;32:223–230.
[9] Appenrodt B, Grünhage F, Gentemann MG, Thyssen L, Sauerbruch T,
Lammert F. Nucleotide-binding oligomerization domain containing 2
(NOD2) variants are genetic risk factors for death and spontaneous bacterial
peritonitis in liver cirrhosis. Hepatology 2010;51:1327–1333.
[10] Moore CE, Segal S, Berendt AR, Moore CE, Segal S, Berendt AR, et al. Lack of
association between toll-like receptor 2 polymorphisms and susceptibility
to severe disease caused by Staphylococcus aureus. Clin Diagn Lab Immunol
2004;11:1194–1197.
Tony Bruns⇑
Philipp A. Reuken
Division of Gastroenterology, Hepatology, and Infectious Diseases,
Department of Internal Medicine II, Jena University Hospital,
Friedrich Schiller University, Jena, Germany
The Integrated Research and Treatment Center for Sepsis Control and
Care (CSCC), Friedrich Schiller University, Jena, Germany⇑ Corresponding author. Address: NIHR Biomedical Research Unit
and Centre for Liver Research, Institute of Biomedical Research,
University of Birmingham, Edgbaston, Birmingham B15 2TT,
United Kingdom. Tel.: +44 121 414 6846; fax: +44 121 415 8701
E-mail address: t.bruns@bham.ac.uk (T. Bruns)
Janett Fischer
Thomas Berg
Division of Gastroenterology and Rheumatology,
Section of Hepatology, University Hospital Leipzig, Germany
Andreas Stallmach
Division of Gastroenterology, Hepatology, and Infectious Diseases,
Department of Internal Medicine II, Jena University Hospital,
Jena, Germany
The Integrated Research and Treatment Center for Sepsis Control and
Care (CSCC), Jena, Germany
Reply to: ‘‘Further evidence for the relevance of TLR2 gene variants
in spontaneous bacterial peritonitis’’
To the Editor:
The potential role of speciﬁc TLR2 gene polymorphisms as
host risk factors for spontaneous bacterial peritonitis
We are grateful for the comments of Bruns and co-workers,
which together with our report suggest a role of TLR2 in the
defence against bacterial infection of ascites. First, they con-
ﬁrmed the trend observed in our study that the TLR2 Arg753Gln
polymorphism might be a potential risk factor for spontaneous
bacterial peritonitis (SBP) in end-stage liver cirrhosis. On the
other hand their study produced divergent results concerning
the TLR2 16934A>T polymorphism. This draws attention to
some limitations of the studies, in particular the fact that causa-
tive organisms had been identiﬁed only infrequently. In our
study, we observed a signiﬁcant contribution from Gram-positive
organisms, possibly reﬂecting the broad use of antibiotic prophy-
laxis mainly targeted against Gram-negative agents, while details
of the bacterial spectrum were not disclosed in the report by
Bruns et al. Thus, we cannot exclude the possibility that the
TLR2 polymorphisms might confer differential susceptibility to
distinct groups of micro-organisms.
Beyond that, the data in the report of Bruns and co-workers
have not been corrected for potential confounders. Thus, it might
be possible that their apparent association between the TLR2
Arg753Gln polymorphism and SBP might actually reﬂect the cor-
relation between this polymorphism and ascitic protein levels in
their study population. In contrast, we performed Cox regression
analysis, which identiﬁed protein concentration, the presence of
NOD2 risk alleles and GT-repeats greater than 20 in both alleles,
in intron 2 of the TLR2 gene, as independent risk factors for SBP.
Indeed, we assume that the GT repeat polymorphism rather than
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